N-(4-methoxyphenyl)-5-methylfuro[2,3-d]pyrimidin-4-amine

ID: ALA4245874

PubChem CID: 57428969

Max Phase: Preclinical

Molecular Formula: C14H13N3O2

Molecular Weight: 255.28

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1ccc(Nc2ncnc3occ(C)c23)cc1

Standard InChI:  InChI=1S/C14H13N3O2/c1-9-7-19-14-12(9)13(15-8-16-14)17-10-3-5-11(18-2)6-4-10/h3-8H,1-2H3,(H,15,16,17)

Standard InChI Key:  CJKIPQGVCWHDDT-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 19 21  0  0  0  0  0  0  0  0999 V2000
    2.6813  -13.3639    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6801  -14.1835    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3882  -14.5924    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3864  -12.9551    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0950  -13.3603    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0998  -14.1789    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8798  -14.4274    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.3572  -13.7623    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8721  -13.1029    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3840  -12.1379    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.0904  -11.7272    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7973  -12.1360    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5033  -11.7260    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5013  -10.9079    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7874  -10.5016    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0843  -10.9140    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2072  -10.4963    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.9167  -10.9018    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1200  -12.3242    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9  5  1  0
  4 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
 14 17  1  0
 17 18  1  0
  9 19  1  0
M  END

Associated Targets(Human)

A-431 (6446 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDGFRB Tclin Platelet-derived growth factor receptor beta (5195 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KDR Tclin Vascular endothelial growth factor receptor 2 (20924 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EGFR Tclin Epidermal growth factor receptor erbB1 (33727 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TUBB4B Tclin Tubulin (5180 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-435 (38290 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Chorioallantoic membrane (375 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 255.28Molecular Weight (Monoisotopic): 255.1008AlogP: 3.28#Rotatable Bonds: 3
Polar Surface Area: 60.18Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 2.20CX LogP: 2.97CX LogD: 2.97
Aromatic Rings: 3Heavy Atoms: 19QED Weighted: 0.78Np Likeness Score: -0.63

References

1. Devambatla RKV, Choudhary S, Ihnat M, Hamel E, Mooberry SL, Gangjee A..  (2018)  Design, synthesis and preclinical evaluation of 5-methyl-N4-aryl-furo[2,3-d]pyrimidines as single agents with combination chemotherapy potential.,  28  (18): [PMID:30098869] [10.1016/j.bmcl.2018.07.039]
2. Devambatla RK, Namjoshi OA, Choudhary S, Hamel E, Shaffer CV, Rohena CC, Mooberry SL, Gangjee A..  (2016)  Design, Synthesis, and Preclinical Evaluation of 4-Substituted-5-methyl-furo[2,3-d]pyrimidines as Microtubule Targeting Agents That Are Effective against Multidrug Resistant Cancer Cells.,  59  (12): [PMID:27213719] [10.1021/acs.jmedchem.6b00237]

Source